Inter Parfums
This article was originally published in The Rose Sheet
Executive Summary
Fragrance marketer will introduce fragrances and complementary products under the Van Cleef & Arpels brand name per a licensing agreement with the jewelry designer, Inter Parfums announces Oct. 4. The license will run for 12 years, and each party has the right to extend the term for five years on or before June 1, 2018 if certain sales targets are met, firm notes. The deal represents an important step in Inter Parfums development, according to Inter Parfums CEO Jean Madar. "We believe its growth potential will strengthen opportunities for expansion of our fragrance business in the high luxury segment," he says. Concurrently, Van Cleef & Arpels' most recent fragrance licensee, YSL Beaute, has signed an agreement for early termination of its contract with the jewelry brand, a move that will allow YSL to focus on core fragrances. Van Cleef & Arpels fragrances include First, Tsar and Van Cleef & Arpels...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.